Sánchez Guixé, M. (2019). ER+ metastatic breast cancer targeted therapy: Biomarkers of response and mechanisms of resistance to PI3K and FGFR inhibitors.
Citação norma ChicagoSánchez Guixé, Mònica. ER+ Metastatic Breast Cancer Targeted Therapy: Biomarkers of Response and Mechanisms of Resistance to PI3K and FGFR Inhibitors. 2019.
Citação norma MLASánchez Guixé, Mònica. ER+ Metastatic Breast Cancer Targeted Therapy: Biomarkers of Response and Mechanisms of Resistance to PI3K and FGFR Inhibitors. 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.